搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
17 小时
Lantern Pharma获得FDA三项罕见病认定
DALLAS - 利用人工智能(AI)进行癌症药物开发的生物制药公司Lantern Pharma Inc. (NASDAQ:LTRN)宣布,其研究性药物LP-184获得美国食品和药物管理局(FDA)三项罕见儿科疾病认定(RPDD)。这些认定涵盖恶性横纹肌样瘤(MRT)、横纹肌肉瘤(RMS)和肝母细胞瘤,此前该药物已获得非典型畸胎样横纹肌样瘤(ATRT)的RPDD认定。 RPDD认定授予用于治疗美国 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Left note, bail denied
1951 kidnap victim found
Didn't authorize apology
Robinson loses key staff
Trump's Pennsylvania rally
Makes emergency landing
Closing last full-size store
Astronauts return to Earth
Reds fire manager
Returning Indian antiquities
Visits US ammunition plant
Dolphins legend Morris dies
More troops to Middle East
California sues ExxonMobil
FBI: Violent crime declined
NE electoral change blocked
Bulls escape MA rodeo
Tech ban proposed
Co-founder testifies
Colo. shooter found guilty
Asks to be put on NY ballot
NY reports death from EEE
Texas sues Biden admin
1/3 think they have CTE
Gulf Coast storm warning
SpaceX plans Mars missions
No govt. shutdown for now
Economic speech this week
Free COVID-19 tests
Friedkin set to buy Everton
反馈